Cure Alzheimer's Fund Welcomes New Research Management Leader
Cure Alzheimer's Fund Welcomes New Research Management Leader
Cure Alzheimer's Fund is thrilled to announce the appointment of Natasha Hussain, Ph.D., as the new Executive Vice President for Research Management. In her new role, Dr. Hussain is poised to manage and enhance the research opportunities and funding initiatives within the organization.
Bringing Expertise to Alzheimer’s Research
Dr. Hussain will play a crucial role in introducing innovative ideas and perspectives to the organization's research portfolio. Her experience will be invaluable as she collaborates with the scientific community to further Cure Alzheimer's Fund's mission: to prevent, slow, or reverse Alzheimer’s disease.
A Strong Background in Neuroscience
According to Meg Smith, the CEO of Cure Alzheimer's Fund, "Dr. Hussain's experience accelerating discovery and innovation in brain health aligns closely with our mission. Her leadership will help strengthen our work and foster collaborations across the scientific community as we continue advancing Alzheimer's research. We are delighted to welcome her to the CureAlz team."
Dr. Hussain brings with her extensive experience in advancing neuroscience and cross-disciplinary research initiatives. Recently, she served as the inaugural Associate Director of the Knight Initiative for Brain Resilience at Stanford University, where her focus was on strategic programming and partnerships aimed at accelerating discovery in brain health and longevity. Before her time at Stanford, she held the position of Scientific Director at the Kavli Neuroscience Discovery Institute at Johns Hopkins University, where she was instrumental in fostering collaboration between neuroscientists, engineers, and data scientists.
Educational Background and Research Contributions
Dr. Hussain's academic journey began at McGill University, where she earned a Bachelor of Science degree in biology and environmental science, followed by a Ph.D. in neurology and neurosurgery. Her academic and professional experiences underscore her commitment to understanding the intricacies of brain function, including conducting postdoctoral research at the MIT Picower Institute for Learning and Memory. Here, she investigated how brain connections can adapt to experiences and the potential disruptions that could lead to disorders such as schizophrenia.
About Cure Alzheimer’s Fund
Cure Alzheimer's Fund is a nonprofit organization dedicated to funding innovative research aimed at preventing, slowing, or reversing Alzheimer’s disease. Since its inception in 2004, the Fund has awarded over 990 grants to more than 320 leading researchers across 18 countries, investing over $230 million in research programs. Their initiatives have led to significant breakthroughs in understanding the causes and pathology of Alzheimer’s disease.
The organization has achieved an impressive 100% score and a Four-Star rating from Charity Navigator for 13 consecutive years, showcasing its commitment to transparency and effective use of donations. Additionally, Cure Alzheimer’s Fund has received a Platinum Seal of Transparency from Candid, ensuring that 100% of general donations are directed to research programs.
For more detailed information, visit CureAlz.org.
Media Contact
For media inquiries, please contact Barbara Chambers at 978-417-9890.
Frequently Asked Questions
Who is Natasha Hussain?
Natasha Hussain, Ph.D., is the new Executive Vice President for Research Management at Cure Alzheimer's Fund, known for her extensive background in neuroscience.
What is the mission of Cure Alzheimer's Fund?
The mission is to fund research that aims to prevent, slow, or reverse Alzheimer's disease, focusing on innovative scientific approaches.
What are the achievements of Cure Alzheimer’s Fund?
The Fund has surpassed $230 million in research funding, awarded over 990 grants, and received high ratings from Charity Navigator.
Where did Dr. Hussain previously work?
Prior to joining Cure Alzheimer's Fund, Dr. Hussain worked at Stanford University and Johns Hopkins University, focusing on brain research and collaborations.
How can I contact Cure Alzheimer's Fund?
You can reach them through media contact Barbara Chambers at 978-417-9890 for any inquiries related to their research and initiatives.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.